Orphazyme A/S ADR (ORPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2001 | 03-2001 | 12-2000 | 09-2000 | 06-2000 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 420 | 450 | 220 | 60 | 100 |
| TOTAL | $420 | $450 | $220 | $60 | $100 |
| Non-Current Assets | |||||
| PPE Net | 430 | 460 | 460 | 400 | 410 |
| Other Non-Current Assets | 3 | 8 | 10 | 20 | 20 |
| TOTAL | $433 | $468 | $470 | $420 | $430 |
| Total Assets | $853 | $918 | $690 | $480 | $530 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 350 | 240 | 1,290 | 940 | 1,030 |
| Accrued Expenses | 2,320 | 2,270 | 2,750 | 3,240 | 2,240 |
| Other current liabilities | 430 | 430 | 500 | 0 | 0 |
| TOTAL | $3,100 | $2,940 | $4,540 | $4,180 | $3,270 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,100 | $2,940 | $4,540 | $4,180 | $3,270 |
| Shareholders' Equity | |||||
| Common Shares | 80 | 80 | 80 | 80 | 80 |
| Other shareholders' equity | 0 | -4 | -10 | -8 | -7 |
| TOTAL | $58,490 | $58,476 | $57,910 | $57,712 | $57,243 |
| Total Liabilities And Equity | $61,590 | $61,416 | $62,450 | $61,892 | $60,513 |